Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
McKinsey
Fuji
McKesson
Express Scripts
Mallinckrodt
QuintilesIMS
Teva

Generated: August 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208328

« Back to Dashboard

NDA 208328 describes MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE, which is a drug marketed by Amneal Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE profile page.

The generic ingredient in MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE is donepezil hydrochloride; memantine hydrochloride. There are thirty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride; memantine hydrochloride profile page.
Summary for 208328
Pharmacology for NDA: 208328
Suppliers and Packaging for NDA: 208328
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208328 ANDA Amneal Pharmaceuticals LLC 69238-1247 N 69238-1247-3
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208328 ANDA Amneal Pharmaceuticals LLC 69238-1247 N 69238-1247-9

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength10MG;14MG
Approval Date:Jan 27, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength10MG;28MG
Approval Date:Jan 27, 2017TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Covington
Farmers Insurance
McKesson
Healthtrust
AstraZeneca
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.